Esther Ozor
Family · Silver Spring, MDNPI 1538665294
Payments from drug & device makers
Across 36 payments — averaging $90.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Boston Scientific$242
- Medtronic$224
- Abbott$182
- Tersera Therapeutics LLC$106
- Vertos Medical, Inc.$45
- plus $65 from 3 others
What the payments were for
- Travel & lodging$1,09034%
- Food & beverage$1,13935%
- Education$1,02431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 15 | $2,389 |
| Boston Scientific | 5 | $242 |
| Medtronic | 5 | $224 |
| Abbott | 3 | $182 |
| Tersera Therapeutics LLC | 4 | $106 |
| Vertos Medical, Inc. | 1 | $45 |
| Globus Medical | 1 | $26 |
| Relievant Medsystems, Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$2,131
- INCEPTIV$140
- Infinion 16$137
- ETERNA$133
How this compares
$3,252 in reported general payments places this provider in the 85th percentile of 2,843 family providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 60 | $22,500 |
| NucyntaTapentadol Hcl | 15 | $12,658 |
| Fentanyl | 99 | $9,937 |
| Buprenorphine | 42 | $7,970 |
| Oxycodone Hcl | 281 | $5,579 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 172 | $3,926 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 110 | $3,211 |
| Pregabalin | 103 | $2,918 |
| Morphine Sulfate ErMorphine Sulfate | 95 | $2,471 |
| Lidocaine | 22 | $2,323 |
| Gabapentin | 137 | $2,275 |
| Hydromorphone Hcl | 92 | $1,194 |
| Morphine Sulfate | 33 | $1,175 |
| Duloxetine Hcl | 27 | $1,054 |
| Naloxone Hcl | 15 | $1,047 |
Paid to pharmacies, not to this prescriber.
Other family in Silver Spring
- Tyris FordSilver Spring$12K
- Ritchell VillaluzSilver Spring$9K
- Kelly MercadoSilver Spring$9K
- Ariana ChaoLutherville$727K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Meredith SagalHunt Valley$82K
- Sharon Dudley-BrownBel Air$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.